Editorial

AI can find hidden heart disease in routine ECGs. The policy challenge is deciding who gets fast-tracked

Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty

C. Diff Can Hide in Plain Sight.

Radiopharmaceuticals Just Got a Necessary No

Alzheimer’s Blood Tests Are Becoming the Gate

WHO Rewrote the Typhoid Playbook

Sprint interval training triggered a bigger molecular response than 90 minutes of cycling. Bigger is not yet better
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
